Literature DB >> 17460613

Ventral striatal blood flow is altered by acute nicotine but not withdrawal from nicotine.

Jody Tanabe1, Thomas Crowley, Kent Hutchison, David Miller, Glyn Johnson, Yiping P Du, Gary Zerbe, Robert Freedman.   

Abstract

Neural mechanisms underlying the reinforcing effects of nicotine and other drugs have been widely studied and are known to involve the ventral striatum, which is part of the mesocorticolimbic dopamine system. In contrast, mechanisms of nicotine withdrawal have received less attention although subjective withdrawal likely contributes to the difficulty of quitting. The goal of this study was to determine if nicotine withdrawal was associated with alterations of cerebral blood flow (CBF) in ventral striatum. Twelve smokers, moderately dependent on nicotine, underwent MR dynamic susceptibility contrast (DSC) imaging at baseline, after overnight withdrawal from nicotine, and after nicotine replacement. DSC images were used to calculate CBF in three regions of interest: ventral striatum, thalamus, and medial frontal cortex. Subjective withdrawal symptoms were measured at each time point. In spite of significant subjective withdrawal symptoms, there was no main effect of withdrawal on CBF in the three regions. However, there was a significant correlation between the increase in withdrawal symptoms and a reduction in thalamic CBF. In contrast to withdrawal, nicotine replacement significantly increased CBF in ventral striatum. Our findings are consistent with the known role of ventral striatum in drug reward. The lack of a main effect on withdrawal, but correlation of thalamic blood flow with withdrawal symptoms suggests that more complex mechanisms mediate the subjective features of the withdrawal state.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460613      PMCID: PMC2856639          DOI: 10.1038/sj.npp.1301428

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  33 in total

1.  Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging.

Authors:  Timothy J Carroll; Howard A Rowley; Victor M Haughton
Journal:  Radiology       Date:  2003-03-27       Impact factor: 11.105

2.  Structural MR image processing using the BRAINS2 toolbox.

Authors:  Vincent A Magnotta; Greg Harris; Nancy C Andreasen; Daniel S O'Leary; William T C Yuh; Dan Heckel
Journal:  Comput Med Imaging Graph       Date:  2002 Jul-Aug       Impact factor: 4.790

3.  Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence.

Authors:  Jon-Kar Zubieta; Mary M Heitzeg; Yanjun Xu; Robert A Koeppe; Lisong Ni; Sally Guthrie; Edward F Domino
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

Review 4.  Contrast agents and cerebral hemodynamics.

Authors:  B R Rosen; J W Belliveau; B R Buchbinder; R C McKinstry; L M Porkka; D N Kennedy; M S Neuder; C R Fisel; H J Aronen; K K Kwong
Journal:  Magn Reson Med       Date:  1991-06       Impact factor: 4.668

5.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis.

Authors:  L Ostergaard; R M Weisskoff; D A Chesler; C Gyldensted; B R Rosen
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

Review 6.  Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.

Authors:  N L Benowitz
Journal:  N Engl J Med       Date:  1988-11-17       Impact factor: 91.245

7.  Time course of cigarette withdrawal symptoms while using nicotine gum.

Authors:  R West; P Hajek; M Belcher
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Dramatic decreases in brain reward function during nicotine withdrawal.

Authors:  M P Epping-Jordan; S S Watkins; G F Koob; A Markou
Journal:  Nature       Date:  1998-05-07       Impact factor: 49.962

9.  Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.

Authors:  O Mawlawi; D Martinez; M Slifstein; A Broft; R Chatterjee; D R Hwang; Y Huang; N Simpson; K Ngo; R Van Heertum; M Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2001-09       Impact factor: 6.200

10.  Effects of nicotine on cognitive deficits in schizophrenia.

Authors:  Josette G Harris; Susan Kongs; Diana Allensworth; Laura Martin; Jason Tregellas; Bernadette Sullivan; Gary Zerbe; Robert Freedman
Journal:  Neuropsychopharmacology       Date:  2004-07       Impact factor: 7.853

View more
  14 in total

1.  Neural substrates of abstinence-induced cigarette cravings in chronic smokers.

Authors:  Ze Wang; Myles Faith; Freda Patterson; Kathy Tang; Kia Kerrin; E Paul Wileyto; John A Detre; Caryn Lerman
Journal:  J Neurosci       Date:  2007-12-19       Impact factor: 6.167

Review 2.  Homers regulate drug-induced neuroplasticity: implications for addiction.

Authors:  Karen K Szumlinski; Alexis W Ary; Kevin D Lominac
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

3.  Effect of varenicline on aspects of inhibitory control in smokers.

Authors:  A J Austin; T Duka; J Rusted; A Jackson
Journal:  Psychopharmacology (Berl)       Date:  2014-03-21       Impact factor: 4.530

Review 4.  Neuroimaging, genetics and the treatment of nicotine addiction.

Authors:  Riju Ray; James Loughead; Ze Wang; John Detre; Edward Yang; Ruben Gur; Caryn Lerman
Journal:  Behav Brain Res       Date:  2008-06-05       Impact factor: 3.332

5.  The "anhedonia paradox" in schizophrenia: insights from affective neuroscience.

Authors:  Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2010-05-15       Impact factor: 13.382

Review 6.  Neuroimaging for drug addiction and related behaviors.

Authors:  Muhammad A Parvaz; Nelly Alia-Klein; Patricia A Woicik; Nora D Volkow; Rita Z Goldstein
Journal:  Rev Neurosci       Date:  2011-11-25       Impact factor: 4.353

7.  MEMRI is a biomarker defining nicotine-specific neuronal responses in subregions of the rodent brain.

Authors:  Aditya N Bade; Howard E Gendelman; Michael D Boska; Yutong Liu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

8.  Design and validation of an improved nonferrous smoking device for self-administration of smoked drugs with concurrent fMRI neuroimaging.

Authors:  K P Lindsey; S E Lukas; R R MacLean; E T Ryan; K R Reed; B deB Frederick
Journal:  Clin EEG Neurosci       Date:  2009-01       Impact factor: 1.843

9.  Transcranial Direct Current Stimulation Applied to the Dorsolateral and Ventromedial Prefrontal Cortices in Smokers Modifies Cognitive Circuits Implicated in the Nicotine Withdrawal Syndrome.

Authors:  Sarah Aronson Fischell; Thomas J Ross; Zhi-De Deng; Betty Jo Salmeron; Elliot A Stein
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-01-13

10.  Nicotine abstinence-induced cerebral blood flow changes by genotype.

Authors:  Ze Wang; Riju Ray; Myles Faith; Kathy Tang; E Paul Wileyto; John A Detre; Caryn Lerman
Journal:  Neurosci Lett       Date:  2008-04-29       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.